ÂÜÀòÂÒÂ×

James F. Markmann MD, PhD is the Chief of the Division of Transplant Surgery and Director of Clinical Operations at the Transplant Center at Massachusetts General Hospital, the Claude Welch Professor of Surgery at Harvard Medical School and co-Director for the Center for Transplantation Sciences at MGH. Clinically, he specializes in liver, kidney, pancreas and islet transplantation as well as hemodialysis access surgery. He is active in numerous societies, editorial boards and organizations and is currently President of the International Pancreas and Islet Transplant Association and Treasurer the American Society of Transplant Surgeons. He has published more than 400 scientific papers over the last 30 years, most in the area of immune tolerance and pancreas and islet transplantation and has held continuous NIH R01 funding for >20 years. His current research focuses on development of beta cell replacement as a curative cellular therapeutic with broad applicability for patients with insulin deficient diabetes.